作者: Brian S. Ladman , Jack Gelb , Lauren A. Sauble , Marcella V. Murphy , Erica Spackman
DOI: 10.1080/03079457.2019.1605148
关键词: RNA 、 Alphavirus 、 Influenza A virus subtype H5N1 、 Virology 、 Immunity 、 Replicon 、 Inactivated vaccine 、 Vaccination 、 Highly Pathogenic Avian Influenza Virus 、 Biology
摘要: The efficacies of an oil adjuvanted-inactivated reverse genetics-derived H5 avian influenza virus (AIV) vaccine and alphavirus replicon RNA particle (RP) AIV were evaluated in commercial...